CXCL13 and angioimmunoblastic T-cell lymphoma: CXCL13 has been proposed as a biomarker and is included in the diagnostic criteria for angioimmunoblastic T-cell lymphoma (AITL), an aggressive nodal T cell lymphoma [41].